Incidence and risk factors associated with the development of cytomegalovirus disease after intestinal transplantation.
about
Clinical utility of viral load in management of cytomegalovirus infection after solid organ transplantationNew strategies for prevention and therapy of cytomegalovirus infection and disease in solid-organ transplant recipientsInfectious complications after small bowel transplantation in adults: an update.Cytomegalovirus infection after intestinal transplantation in childrenCurrent status of intestinal transplantation in children.The current status of hepatic transplantation at the University of PittsburghHepatic transplantation at the University of Pittsburgh: new horizons and paradigms after 30 years of experience.Organ transplantation for intestinal failure.Small intestinal transplantation for irreversible intestinal failure in childrenDynamics of cell-mediated immune responses to cytomegalovirus in pediatric transplantation recipientsOpportunistic viral infections in intestinal transplantation.Resistant cytomegalovirus in intestinal and multivisceral transplant recipients.Calprotectin: a novel noninvasive marker for intestinal allograft monitoring.Effect of CMV serology on outcome after clinical intestinal transplantation.Pharmacokinetics of oral valganciclovir and intravenous ganciclovir administered to prevent cytomegalovirus disease in an adult patient receiving small-intestine transplantation.Everolimus is associated with a reduced incidence of cytomegalovirus infection following de novo cardiac transplantation.Incidence, risk factors, and outcomes associated with cytomegalovirus disease in small bowel transplant recipients.
P2860
Q26826856-8DE8DE37-A2CB-40B7-986F-70DCE0727F2AQ33812425-ECCFC2D0-19F1-4D6D-92C8-A2BD10551843Q34210775-F0A11E9F-3F2A-4029-94F4-D8CB4713CA8DQ34232361-96343B22-7E16-4A27-9AFF-14884CD953C6Q34251587-E658020A-0360-4B5D-BCE1-5C468F2EC7F5Q34330449-23958992-18C2-4ABD-B948-D9BB2A4BC840Q34498238-788F04E2-98F5-4FDD-8472-84FFA21D989BQ34823494-F4BE5CA3-C311-4BBA-8779-CA4FE3D994C5Q35160335-04C97A0D-0C3D-44B8-80FA-CFECF02BBF73Q35544428-EF4DDE9E-F24E-4C97-BD0A-695A5B77B8D2Q38097119-589FA3B6-7FD3-46E9-927E-E3C2F7875D8CQ38725677-1FC1AB03-C015-41E2-8840-202E6A61F17FQ40187909-1976B6A1-ED0C-4BFD-AB4B-9C2E834994E4Q42408814-FE1431FB-9337-4452-A295-D7937C143EEAQ43189079-CEA0AFEE-B376-4B4F-B4C1-2FB1AE0B1ED2Q43523397-85DE8848-5CC6-4BF2-B82E-39758740E0D4Q51370683-78749797-A629-4BEF-A547-1E2F2699E611
P2860
Incidence and risk factors associated with the development of cytomegalovirus disease after intestinal transplantation.
description
1995 nî lūn-bûn
@nan
1995 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Incidence and risk factors ass ...... er intestinal transplantation.
@ast
Incidence and risk factors ass ...... er intestinal transplantation.
@en
Incidence and risk factors ass ...... er intestinal transplantation.
@nl
type
label
Incidence and risk factors ass ...... er intestinal transplantation.
@ast
Incidence and risk factors ass ...... er intestinal transplantation.
@en
Incidence and risk factors ass ...... er intestinal transplantation.
@nl
prefLabel
Incidence and risk factors ass ...... er intestinal transplantation.
@ast
Incidence and risk factors ass ...... er intestinal transplantation.
@en
Incidence and risk factors ass ...... er intestinal transplantation.
@nl
P2093
P2860
P1433
P1476
Incidence and risk factors ass ...... er intestinal transplantation.
@en
P2093
H Furukawa
K Abu-Elmagd
P2860
P304
P356
10.1097/00007890-199504150-00016
P577
1995-04-01T00:00:00Z